These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6138984)

  • 41. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
    Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
    J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The preparation and characterization of transfer factor (author's transl)].
    Schröder I; Werner H; Lorenz U; Köhler H; Jenssen HL
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):365-71. PubMed ID: 126568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of virus-induced cytotoxic autoreactive T-lymphocytes and T-suppressors in the pathogenesis of an experimental infection in mice cause by the Langat virus].
    Khozinskiĭ VV; Semenov BF
    Vopr Virusol; 1984; 29(3):350-5. PubMed ID: 6087569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transfer factor preparations: some physico-chemical and biological properties.
    Reymond JF; Grob PJ
    Vox Sang; 1975; 29(5):338-51. PubMed ID: 1199022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. UV-absorbance profile of human leukocytic ultrafiltrate after affinity chromatography on immobilized m-aminophenyl boronic acid: implication for transfer factor purification.
    Borvák J; Mayer V
    Acta Virol; 1985 Mar; 29(2):119-28. PubMed ID: 2860795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human transfer factors: structural properties suggested by HPRP chromatography and enzymatic sensitivities.
    Burger DR; Vandenbark AA; Dunnick W; Kraybill W; Daves GD; Vetto RM
    J Immunol; 1979 Mar; 122(3):1091-8. PubMed ID: 448071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human transfer factor prepared by dialysis, ultrafiltration and gel chromatography: biological activity in local transfer of skin sensitivity.
    Lawton JW; Darg C; Pepper D; Kay AB
    J Immunol Methods; 1977; 16(2):119-29. PubMed ID: 881554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography.
    Vandenbark AA; Burger DR; Dreyer DL; Daves GD; Vetto RM
    J Immunol; 1977 Feb; 118(2):636-41. PubMed ID: 839073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chromatographic and enzymatic effects on transfer factor-like activity from human leukocytes and porcine spleen dialysate.
    Karhumäki E; Marnela KM; Krohn K
    Int J Biochem; 1988; 20(10):1067-72. PubMed ID: 3248667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bovine 'transfer factor': an oligoribonucleopeptide which initiates antigen-specific lymphocytes responsiveness.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1982; 4(6):335-50. PubMed ID: 6191411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An efficient method for purification of human T-cell growth factor.
    Acuto O; Cianfriglia M; Colombatti M; Chapuis B; Nabholz M
    J Immunol Methods; 1982 Aug; 53(1):15-26. PubMed ID: 6982298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Augmentation of 3H-thymidine incorporation by human lymphocytes in the presence of antigen and fractions of dialyzable transfer factor: a nonspecific phenomenon.
    Littman BH; Hirschman EM; David JR
    Cell Immunol; 1977 Jan; 28(1):158-66. PubMed ID: 64313
    [No Abstract]   [Full Text] [Related]  

  • 55. [Transfer factor].
    Panizon F; Agosti E; Andolina M
    Pathologica; 1976; 68(983-984):381-91. PubMed ID: 1016407
    [No Abstract]   [Full Text] [Related]  

  • 56. Purification of transfer factors.
    Rozzo SJ; Kirkpatrick CH
    Mol Immunol; 1992 Feb; 29(2):167-82. PubMed ID: 1542296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human transfer factor in vitro: identification of L-serine and glycine as components with augmenting effect in lymphocyte transformation assay.
    Uotila A; Marnela KM; Hamblin A; Krohn K
    Scand J Immunol; 1978; 7(6):495-502. PubMed ID: 684376
    [No Abstract]   [Full Text] [Related]  

  • 58. Obstacles and limitations of transfer factor biological activity assay design.
    Kempová V; Zaťovičová M; Kajanová I; Lenka LJ; Klimko L; Kopáček J; ZelnÍk V
    Acta Virol; 2020; 64(3):271-275. PubMed ID: 32985203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Letter: Uracil in transfer factor.
    Krohn KJ; Uotila A; Gröhn P; Väisänen J
    Lancet; 1975 Dec; 2(7946):1209. PubMed ID: 53691
    [No Abstract]   [Full Text] [Related]  

  • 60. Thermal inactivation of the partially purified murine transfer factor.
    Valásková M; Mayer V; Gajdosová E; Oravec C
    Acta Virol; 1983 Jan; 27(1):92. PubMed ID: 6133439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.